Related Experiment Video

Updated: Mar 18, 2026

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.2K

An HSV-based library screen identifies PP1α as a negative TRPV1 regulator with analgesic activity in models of pain

Bonnie Reinhart1, William F Goins1, Asaff Harel1

  • 1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania, USA.

Molecular Therapy. Methods & Clinical Development
|July 7, 2016
PubMed

Insights

Researchers identified protein phosphatase 1α (PP1α) as a negative regulator of the pain-associated TRPV1 channel using a novel herpes simplex virus (HSV) vector system. This discovery offers a new approach for pain management therapies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Transient receptor potential vanilloid 1 (TRPV1) is a key ion channel implicated in inflammatory and neuropathic pain.
  • Herpes simplex virus (HSV) vector expression of TRPV1, in the presence of capsaicin, leads to cell death and blocks viral replication.

Purpose of the Study:

  • To develop a selection system for identifying negative regulators of TRPV1 activity.
  • To discover cellular factors that can inhibit TRPV1 function for potential therapeutic applications.

Main Methods:

  • Utilized an HSV-based coexpression system with a PC12 cell-derived cDNA library to screen for TRPV1 regulators.
  • Employed a selection system based on the rescue of virus replication as a readout for TRPV1 inhibition.
  • Administered vectors expressing identified regulators into rat footpads to assess in vivo efficacy.

Main Results:

  • Identified protein phosphatase 1α (PP1α) as a novel negative regulator of TRPV1, functionally similar to a dominant-negative mutant (PL).
  • HSV vectors expressing PP1α or PL significantly reduced thermal sensitivity in rats.
  • These regulators did not affect responses to cold pain (menthol/icilin) or formalin, indicating specificity.

Conclusions:

  • Developed a powerful selection system for discovering ion channel inhibitors.
  • Protein phosphatase 1α (PP1α) is a functional inhibitor of TRPV1 in vivo, with potential for pain modulation.
  • The identified TRPV1 inhibitors demonstrate specificity, targeting thermal pain pathways.

More Related Videos

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice06:04

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice

Published on: September 2, 2020

9.0K
Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV412:09

Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4

Published on: December 31, 2013

10.7K

Related Concept Videos

Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
34.8K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K